WHO is rushing emergency health supplies to refugees from Nagorno-Karabakh who have fled over the border to Armenia

WHO said it is racing emergency health supplies to Armenia, struggling to cope with over 100,000 refugees who have poured over the border from the ethnic Armenian enclave of Nagorno-Karabakh over the past 10 days. 

The enclave, controlled by an ethnic Armenian separatist group since 1994, was retaken by Azerbaijan in a lightning-style military campaign that began on 19 September and lasted about 24 hours.  

The Armenian government said Monday that 100,514 of the region’s estimated 120,000 residents have crossed into Armenia. Eyewitnesses said that the regions capital city, Stepanakert, was virtually deserted. 

In a press release, WHO said that it was rushing emergency health supplies to the Armenian Ministry of Health – to cope with the refugees’ arrival. It is the second such mass exodus event to be witnessed in Europe recently, following Russia’s invasion of Ukraine in February 2022. 

“WHO had already pre-positioned trauma supplies to Armenia,” said WHO’s Regional Director for Europe, Hans Kluge.  

“Following the dramatic explosion of a fuel depot along the route taken by those entering Armenia, WHO is dispatching burns kits to support the advanced care needed for severe burns patients,” Kluge said. He was referring to the massive fuel depot explosion on September 25 amid the exodus. The blast killed at least 170 people and injured 200 more.

“We’ve activated our emergency systems and will be sending experts to the country across a range of disciplines including mental health, burns management, essential health services, and emergency coordination following a full assessment of the needs. 

“To support the general health needs of the displaced population, WHO is also sending medicines for non-communicable diseases, that will cover 3 months of treatments for up to 50,000 persons,” Kluge added, saying “The challenges are truly enormous, and we’re there to do all we can.”

A WHO special envoy, Robb Butler, has also been dispatched to Armenia to assess more long term needs. 

“At the first major town the refugees are fleeing to, I saw an immense outpouring of solidarity from the local Armenian community and volunteers, who are doing all they can to provide food, water and shelter,” said Butler.

“But you see the despair on many of the faces of the displaced. They have left everything behind, their homes, their belongings, the graves of their loved ones. There are children, the elderly, women and girls with specific sexual and reproductive health needs. It’s clear that the mental and emotional scars the refugees carry will take time to heal. But it’s also obvious that the staggering speed with which this crisis is unfolding requires all hands on-deck – WHO, our UN partners, civil society organizations – to complement and support the government’s efforts. 

Image Credits: WHO/Nazik Armenakyan .

Germany’s Health Minister, Karl Lauterbach, and Minister for Economic Cooperation and Development, Svenja Schulze.

German Ministers urge more investment in the Pandemic Fund and universal health coverage at a high-level pandemic preparedness meeting 

Even if vaccines and medicines are developed at record speed to address the next ominous global pathogen, they cannot prevent a pandemic without strong health systems to deliver them, stressed politicians and health leaders at a meeting convened by Germany’s ministries of health and economic development.

Primary health care is the “basis” of all responses to disease outbreaks and crises, stressed Dr Mike Ryan, the World Health Organization’s (WHO) head of health emergencies at the Berlin meeting on pandemic preparedness on 28 September.

“The simple availability of a countermeasure is in no way a guarantee that they will be delivered to the people who need them,” said Ryan, pointing out that there were vaccines for many of the current global disease outbreaks – from measles to diphtheria.

Karl Lauterbach, Germany’s Federal Minister of Health, said that the annual cost of rolling out universal health coverage (UHC) was estimated to be $350 billion.

“Now everyone will think: ‘$350 billion, that’s enormous. Who’s going to pay for that?’ But on the other hand, we spend more than $7000 billion dollars for subsidies for fossil energy, which is only contributing toward climate change,” said Lauterbach.

“Wouldn’t it be a much better world if we cut a lot of our fossil energy subsidies and spend some of that money on universal health coverage? It would be definitely a more equitable world it would be a more just world and it would clearly also be safer,” he added.

Meanwhile, WHO Chief Scientist Jeremy Farrar, warned that “the pandemic will fade from memory, and if governments don’t find utility and value in what they’re investing in every Monday, every Tuesday, every September and October, then they won’t continue to invest in it. 

“So invest in the basic science, invest in people, invest in institutions, and make sure we build trust in institutions and make sure that they are part of our culture rather than something done in ivory towers by people in white coats,” Farrar urged the meeting, which was convened partly to take stock of what is needed to address future pandemics.

WHO Chief Scientist Jeremy Farrar.

Need for pandemic treaty to set mandatory rules

Lauterbach said that we may soon be  “living in the era of pandemics”, as warned by Farrar. This is being driven by biodiversity loss, which makes it increasingly possible for the “10,000 viruses harboured in animals” to infect people, and the “exponential increase in migration”, he explained.

To address the growing threats, the pandemic agreement currently being negotiated at the WHO needs to “have clearly defined responsibilities that are also mandatory” to maximise the “golden gap” between outbreaks and a pandemic, he urged.

He also expressed support for a “pathogen access benefit-sharing system”, one of the potential sticking points of the pandemic accord. African countries, in particular, want to be compensated for sharing information about pathogens while the pharmaceutical sector says this will slow the response to international outbreaks.

“Across the globe, people have come to realise that no one is safe until everybody is safe. But this is not only true for pandemic times. Health is literally a global public good that must be accessible to all people worldwide,” said Svenja Schulze, German Federal Minister for Economic Cooperation and Development, who co-hosted the meeting.

For Schulze, the pandemic treaty would provide “an international framework for communication and action, which creates trust and sets the rules”. 

“This will lay the ground for a swift exchange of data and a fair distribution of vaccines and medicines, and I hope that the agreement will be concluded as soon as next year because pandemic prevention will either work globally or not at all,” she said.

Pointing to outbreaks of dengue fever in parts of Europe as the world warmed up, Schulze, said that “as a result of climate change and globalisation, diseases are spreading to world regions that were previously unaffected”.

However, Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), urged pandemic treaty negotiators to protect innovation and factor in pharma’s offer (in its Berlin Declaration) to make a percentage of pandemic goods to low-income countries in real-time.

IFPMA Director-General Thomas Cueni.

“Few people talk about the risk of failing,” added Cueni. “When you look at the vaccine situation pre-pandemic, three of the world’s largest vaccine manufacturers flopped…. We were lucky to have a pretty much unknown biotech company in Germany and another one in the US coming up with the mRNA vaccine, and the collaboration between Oxford University and AstraZeneca and also the Johnson and Johnson vaccine. 

“Eighty-five percent of the vaccines used by COVAX for the low-income countries in 2021 came from four innovative companies, which means when I look at the pandemic treaty negotiations, we really need to make sure that what worked – the innovation ecosystem,  which went back more than 20 years – is not compromised.”

Pointing out that low and middle-income countries were unable to get vaccines because the Indian government prevented the Serum Institute of India (SII) from exporting its generic vaccines, Cueni added that a joint partnership including the private sector needs to “focus on how can we improve diversity of vaccine manufacturing geographically”.

Germany ups emergency support, appeals for more Pandemic Fund resources 

Germany agreed last week to contribute a further €40 million to WHO’s work in health emergencies and also signed a long-term agreement to support the new Berlin-based WHO Hub for Pandemic and Epidemic Intelligence. With the new contribution, Germany has provided €53.5 million this year to support WHO’s response to more than 50 active health emergencies.

Meanwhile, Schulze said that the health sector could not build stronger health systems alone: “Development banks need to do their bit and that is why I have joined with other shareholders to initiate a reform of the World Bank. It must step up investments in global public goods, including in the health sector. Other development banks should do the same.”

She also appealed for stronger cooperation with the private sector, pointing out that Germany “is providing more than €550 million under the framework of a European national initiative to support efforts to develop [vaccine] production capacities in Africa, especially in Ghana, Rwanda, Senegal and South Africa”.

Schulze also appealed for other countries to support the Pandemic Fund, currently hosted by the World Bank. Germany is one of the biggest contributors to the fund.

Pandemic Action Network (PAN) co-founder Carolyn Reynolds described the Pandemic Fund as “one of the bright spots that have come out of the past three years in terms of global action”, but added that  $2 billion has been committed so far while $10.5 billion is needed a year to address gaps in pandemic preparedness.

“We can get there but it’s all about political results and leadership,” said Reynolds.

WHO’s Ryan pointed out that, before the pandemic, “106 countries had national action plans for public health security”. 

“They had gone through joint external evaluation they had done after action reviews, they had carried out exercises and simulations to test their system. They had identified the weaknesses in their system. Can you hazard a guess about how many of those plans got funding from the international community of the 106? Three,” said Ryan.

“Therein lies the seeds of the pandemic impact. Countries knew what was wrong. They knew what was missing. But we simply did not have the governance and financial architecture to change the dial. And we didn’t have the capacity to deliver the systems that were needed to make good on the needs of those plans.”

Mike Ryan (left) and Svenja Schulze, German Minister for Economic Cooperation and Development.

WHO officials welcome UN pandemic declaration

While Reynolds was disappointed by the lack of ​​”political resolve and call to action” at the recent United Nations (UN) High-Level Meeting on Pandemic Prevention, Preparedness and Response, Farrar and Ryan expressed support for the Political Declaration adopted by the meeting.

“Political declarations do matter,” said Farrar. “Try and achieve something global health without political support. You can’t. Does political support translate into action? No, not necessarily. And that’s why pushing the political class is so important.”

It’s the first time in the history of the United Nations that all member states came together and said anything about this, so I’ll take it,” said Ryan.

“World leaders came together. They’ve agreed to recognise the impact of the pandemic. They agreed to say: ‘We can never let this happen again.’ They’ve identified a number of areas in which we need to make progress. 

“Now, the ball is back with us. We’ve got the negotiations on the [pandemic] treaty, we’ve got the revision of the International Health Regulations. We’ve got the Pandemic Fund. We’ve got various initiatives through the G7,” said Ryan.

“I do think that next May [at the World Health Assembly], the countries of the world will come together, I hope, and there will be a solemn agreement between states that says in vernacular terms to the people of the world: ‘Never again’.”

European Union health ministers have not met to discuss the health workforce crisis since 2010.

BAD HOFGASTEIN, Austria — Belgium, which takes over the presidency of the Council of the European Union in January 2024, plans to make the healthcare workforce crisis a central item on its agenda, the first time the issue will be prioritized at the highest level of EU policymaking in over a decade.

“We are actively considering the health workforce and all the challenges around health workforces to be one of the main priorities of the Belgian presidency,” Lieven De Raedt, a strategic advisor on the international unit of the Belgian Federal Ministry of Health, told the European Health Forum in Gastein, Austria, on Thursday.

De Raedt stressed that the Belgian presidency’s agenda is not yet finalized, but confirmed to Health Policy Watch that Belgium will push for an ambitious approach to the future direction of EU health policy.

The Belgian presidency will aim to make the health workforce crisis “one of the main priorities at the EU level for the upcoming years and the next Commission”, De Raedt told the conference. 

Internal dialogues held by Belgian delegations with EU health ministers to determine the priorities of the country’s presidency of the Council of the European Union found that the health workforce crisis is the “main headache for basically all health ministers in the EU and in the WHO European region,” De Raedt said. 

“It is obvious that this is the main challenge in health policy,” he added. 

The clock is ticking on Europe’s health workforce crisis

De Raedt said Belgium aims to make the health workforce crisis a priority of its EU Council presidency.

A rapidly ageing population is putting increasing pressure on European health systems, as the bloc struggles to retain its current health workforce. Alarming numbers of health workers are fleeing to other sectors due to poor working conditions, low pay, and threats to their physical and mental health exacerbated by the strains of the COVID-19 pandemic.

The World Health Organization (WHO) has warned that Europe’s health workforce crisis is a “ticking time bomb”.

Countries in the WHO’s European region, which stretches from the United Kingdom to the plains of Kyrgyzstan and Tajikistan in Central Asia, currently face a shortfall of 1.8 million health workers, and that number is expected to double to 4 million by 2030.

Europe Is Struggling to Keep its Health Systems Afloat

“The number one problem is the health worker crisis we have here in Europe because there is no health without the health workforce,” Dr Hans Kluge, WHO regional director for Europe said on Wednesday. 

Young doctors on the frontlines of the crisis say the numbers bear out a stark reality on the ground facing healthcare workers who want to stay in the health workforce.

“The most important part for us is to retain our workforce,” Alvaro Cerame, chairperson for the Medical Workforce Committee of the European Junior Doctors Association (EJD), told Health Policy Watch. “Our generation does not only have to take care of our children, but because of the demographic changes, we also have to take care of our elders – and with fewer social support structures.”

A meeting of EU health ministers in 2010 saw the crisis coming

Header of the outcome document from 2010 meeting of European health ministers.

Thirteen years after a meeting of European Union health ministers warned of an impending crisis in the bloc’s health workforce, the situation has worsened as EU governments failed to act on the warning signs. 

The outcome document of a 2010 ministerial meeting – titled “Investing in Europe’s health workforce of tomorrow” – called on the bloc’s member states to “invest in sufficient, motivated and well-skilled health professionals in order to protect the viability and accessibility of health systems.”

EU health ministers have not convened to discuss the health workforce crisis since 2010, when Belgium last held the presidency of the EU Council.

While the EU has held consultations and launched projects on health worker migration, skills, empowerment, and workforce planning and forecasting in the years since that meeting, the bloc’s health workforce remains chronically underfunded.

The EU’s 2021 health budget, EU4Health, was the largest ever allocated to the sector, at €5.3 billion. But over half, €2.8 billion, is earmarked for DG HERA, the European Commission’s health emergency preparedness and response unit created to combat COVID-19. Most of this money has been spent on medical countermeasures against the virus such as vaccines.

A modest €2.5 billion is left for non-crisis health spending, with almost none of it going to the health workforce.

“The EU4Health program is €5.3 billion, and so far, only about €10 million has been spent on the health workforce, which is somewhere between 0.1% and 0.2%,” said De Raedt. He emphasized that his calculations are preliminary and do not reflect the official stance of the Belgian government.

Bulgaria produces the 15th most medical doctors in the WHO European region. The country ranks 31st in medical doctors per capita in the region.

EU underinvestment in health workforces stems from their long-held status as a national-level issue, rather than one for EU decision-makers in Brussels. This has left EU countries without a coordinated response to the health workforce crisis.

“Anytime we try to discuss this, at least from my experience, it always devolves into ‘this is a national competence’,” Sara Cerdas, a Portuguese medical doctor and MEP for the European Socialist party, told Health Policy Watch.

“Whereas, as I see it, we should have an EU approach on this because we cannot see 27 health systems in silos and then protect public health together.”

This has exacerbated the crisis in less developed EU countries, such as Bulgaria, which produces many doctors and nurses but loses them to richer countries within the bloc whose health systems can offer higher salaries. 

“It is a no-brainer that the health workforce is a public good across EU member states,” Josep Figueras, director of the European Health Observatory told Health Policy Watch. “If professionals can cross borders, we need to work together [because] unfortunately the migration is only going in one direction.”

Threats identified a decade ago fuelling today’s health workforce crisis

Percentage of doctors over the age of 55 in the WHO European region.

The 2010 ministerial meeting in La Hulpe, a leafy suburb on the outskirts of Brussels, predicted the outlines of Europe’s current health workforce crisis with astounding precision.

The outcome document warned of the urgent need to improve “forecasting future health workforce needs” through the collection of “high-quality and comparable data” across the EU.  

Today, this remains one of the bloc’s biggest blind spots, according to Sandra Gallina, Director General for Health and Food Safety at the European Commission.

“I am a numbers person, and I can tell you we need to improve the measuring of where we are, what we need and where we should be going,” Gallina said at a closed-door media briefing on Wednesday.

“We need to be better at planning and forecasting needs for the workforce – there are medical deserts already appearing,” she added, referring to geographic areas across the EU where people have limited or no access to healthcare services due to staffing shortages.

Another problem identified by the ministerial meeting – “the ageing of the population and of the health workforce” – has not gone away, either. 

Europe’s medical workforce is ageing at a staggering rate. Across Europe, the average doctor is over 55 years old. In 13 countries, at least 40% of doctors are over 55 and will retire within the next decade. Italy has the oldest medical workforce in Europe, with nearly 60% of doctors over 55. 

“That means that in the next few years, more than 40% of these doctors will be retiring,” Tomas Zapata, unit lead for health workforce and health services at WHO’s European Office said on Thursday. 

“That’s a tsunami of retirements,” said Zapata.

Doctors under mounting pressure 

A comic about the health workforce crisis produced by artists at the European Health Forum in Gastein, Austria.

As Europe’s doctors retire and burn out at a rapid pace, the remaining workforce is coming under increasing pressure.

Alvaro Cerame, the young Spanish doctor chairing the European Junior Doctors Association’s Medical Workforce Committee, said it is not uncommon for doctors who come in for 24-hour on-call shifts to continue working without a break up to 36 hours.

The 2010 meeting identified this problem as well, stressing the “importance of attractive working environments [and] working conditions” for “guaranteeing the quality and safety of the care provided”. 

This overstretched workforce is not only harming doctors, nurses, and other healthcare workers but also actively endangering patients.

“There is no doubt that when you work for so many hours — like in any sector — you will not be able to provide quality care, and it is going to put patients at risk,” Cerame said. “States and healthcare systems need to provide safe working conditions for healthcare workers and safe conditions for the patients who are in the healthcare system.”

Where are nurses and medical graduates going? 

Junior doctors are “starting to understand that they are not personally responsible for a failing system”, said Antanas Montvila, Vice-President of the European Junior Doctors Association.

The paradox of Europe’s health worker crisis is that there are more doctors, nurses, and other health workers than ever working in health systems across the region. 

The WHO European region has the most doctors and nurses per capita in the world. Over the past eight years, the region has seen an 8% increase in the density of doctors and a 12% increase in the density of nurses per capita.

But these impressive gains mask a hidden problem: nursing and medical school graduates are not staying in the workforce.

Despite a 37% increase in medical graduates and a 26% increase in nursing graduates in the WHO European region over the past decade, the number of healthcare workers has not kept pace with demand. In fact, Europe’s medical and nursing graduate output has outpaced workforce growth by 29% and 14%, respectively.

The gap is even wider than the WHO figures suggest, as Europe also imports a significant number of healthcare workers from lower-income countries in Africa and Asia. These workers face even bigger retention challenges due to migration policies and visa requirements.

So where are Europe’s medical and nursing graduates going?

“Nobody knows. We have around 30% [of graduates] that are missing somehow, people who are trained but not retained in the health care workforce,” Francisco Ribeiro Mourão, treasurer of the European Junior Doctors Association (EJD), told Health Policy Watch.

The EJD has been trying to fill this knowledge gap and will release a report on the European healthcare workforce next month. But for now, it remains unclear which sectors are gaining the nursing and medical graduates that the health workforce is losing.

“In Austria, for example, like 30% of medical students don’t enter the workforce,” Antatas Montvila, vice president of the EJD and a radiologist in Lithuania, told Health Policy Watch about the findings of the report.

The European Health Observatory’s Figueras cautioned that the report’s methodology and findings, which are not yet public, may require further analysis, telling Health Policy Watch that burnout and workforce migration are the likeliest causes for the gap identified in the report.

Whatever the cause, Europe’s front line doctors see a system that is failing them and their patients.

“According to our research and communicating with our members, we feel that these recent resignations were more or less like silent protests,” Montvila said. “The health system is failing, and it is extremely inefficient.”

“The previous generation, they will still tend to work overtime or in their free time,” Montvila concluded. “But I think that juniors are starting to understand that they are not personally responsible for a failing system.”

‘It’s democracy, man’ 

Sandra Gallina is the Director General for Health and Food Safety at the European Commission.

European Commission officials, health experts, and politicians say that the bloc has the tools to fix its health workforce crisis, but pressure from civil society and voters across Europe must increase if the issue is to rise to the top of the agenda.

“Member states need to ask the Commission, need to ask the elected politicians to push this agenda because the tools are there – it’s all there, it’s just political will, bloody political will,” said Figueras. 

“We need civil society, we need the press, we need a bottom-up push from member states for the EU to take [it] on,” Figueras added. 

Sara Cerdas, the Portuguese doctor and MEP, agreed that pressure from civil society is key, noting the dominance of direct messaging to EU politicians from lobbyists and interest groups compared to its citizens.

“There needs to be more pressure to discuss this at the EU level, and we cannot do that alone as politicians,” said Cerdas.

Gallina, one of the EU’s most senior health officials, echoed a similar sentiment on Wednesday, saying the EU is ready to take action.

“We are all watching this space,” said Gallina. “This is also a matter for voters and citizens to take into their hands.”

“It’s democracy, man,” Gallina said. 

Image Credits: Thijs ter Haar, EHFG.

Dr Muhammad Ali Pate

After working in prestigious international positions, Nigeria’s new health minister has returned to rebuild the health system of Africa’s most populous country.

Excitement turned to disappointment in the global health sector when Dr Muhammad Ali Pate was announced as CEO-designate of the global vaccine alliance, Gavi, then withdrew six weeks before assuming the position.

Pate was an ideal candidate with extensive experience in Africa and globally, including as Nigeria’s health minister, World Bank global director of the Health, Nutrition and Population Global Practice, and Professor of Public Health Leadership at Harvard Chan School of Public Health.

On 22 August, a few weeks after withdrawing from the Gavi position, Pate assumed office as Nigeria’s Coordinating Minister of Health and Social Welfare, a super-ministry that encompasses two huge portfolios – unlike back in 2011 when Pate was appointed as health minister.

A medical doctor trained in both internal medicine and infectious diseases as well as an MBA in health sector management, Pate is renowned for his contributions to combating infectious diseases and the field of public health financing.

Pate’s success rests heavily on his ability to reinvigorate the Nigerian system in Africa’s most populous nation with over 225 million people and numerous disease outbreaks.

In mid-2022, former president Muhammadu Buhari signed Nigeria’s National Health Insurance Authority Bill 2022 into law, declaring that it will provide health insurance coverage for all Nigerians. Buhari also signed new legislation to overhaul mental health care. 

In March 2022, The Lancet Nigeria Commission identified key barriers to optimal health in the country as “ineffective use of available resources, a dearth of robust population-level health and mortality data, insufficient financing for health and health care, sub-optimal deployment of available health funding to purchase health services, and large population inequities”.

Pate was one of the listed authors, which also reported that “about 40% of Nigerians live in poverty, in social conditions that create ill health, and with the ever-present risk of catastrophic expenditures from high out-of-pocket spending for health”.

“We propose an ambitious programme of healthcare reform to deliver a centrally determined, locally delivered health system,” the report declared.

“The goal of government should be to provide health insurance coverage for 83 million poor Nigerians who cannot afford to pay premiums. Implementation of a reinvigorated National Strategic Health Development Plan (NSHDP III) should be supported by structured and explicit approaches to ensure that federal, state and local governments deliver and are held accountable for non-delivery. NSHDP III should be supported by a ring-fenced budget and have a longer horizon of at least a decade during which common rules should apply to all parts of the system.”

Meanwhile, the Ibrahim Abubakar, lead author of the report, described consolidated health insurance as a viable option for solving some of Nigeria’s health financing challenges, based on the previous administration’s introduction of a health insurance law.

Immunization and health workforce

During Pate’s screening process by Nigerian lawmakers before being appointed minister, he stressed the need for the country to spend more on health: “Domestic financing represents the prioritization that we give to health. We’re not spending enough. Even with limited revenue, there is room to increase the allocation for health. Without doing it, inadvertently, we are outsourcing the prioritization of health to external actors.”

With many communicable diseases being entirely preventable with simple and inexpensive vaccines that only cost $1 to $2, Pate also said during the screening process that it is unfortunate that some regions in Nigeria have some of the worst immunization coverage in the world.

“Going forward, under the renewal agenda of the president, I’m pleading that we prioritize investments in health, and investments in the things that can prevent diseases that can protect our children who are the future of this country,” Pate told the lawmakers.

Regarding addressing the emigration of health workers, Pate said this would be tackled via a dual approach of improving the conditions of service: “We need to renew that contract within the context of health to make it more conducive to return the health workers that we produce, to deploy them effectively, to train them where needed and to give them the tools where they can work with those tools to serve.” 

He also pledged support for initiatives to attract the country’s health experts abroad to return to contribute their wealth of experience to improve the country’s health sector and health indices.

Outbreak preparedness 

Before Pate’s nomination, Salma Ibrahim Anas was appointed special adviser on health to the president. Anas said the current administration’s renewed hope aims to attain health for all through an efficient and effective universal health care coverage (UHC) system using the continuum model as contained in the sustainable development goals (SDGs) which Nigeria is committed to.

“The overall goal is to move Nigeria closer to universal health care coverage with a key focus on reducing the gap between those that are in need and those that use health services,” she added.

In addition to the UHC goals, Pate highlighted the need to improve Nigeria’s preparedness for future disease outbreaks which he said entails strengthening public health institutions and agencies, laboratory infrastructures, training frontline health workers and building public trust in health authorities. 

The country faces numerous health threats and outbreaks, the most recent being diphtheria outbreaks.

He also raised the need for Nigeria to prioritize building and expanding its strategic national stockpile of tools that could be in short supply or difficult to procure during global epidemics.

He also stressed the need for Nigeria to invest in “medical industrialization” so that local manufacturing of vaccines, drugs, and other pharmaceutical and medical products can grow in the country.

In an earlier interview, Pate told Health Policy Watch that medical industrialization is a policy that needs to be implemented to provide both the commodities needed and to create jobs.

“There’s a whole value chain in health. Health is not just about the commodities that we use, there’s an economic imperative as well, as we see in many other countries. There is the need to harness and unlock the market potential of the private sector in health, to manufacture, to produce and also to deliver services in terms of capital,” he said.

High hopes

Nigerian lawmaker, Senator Abdul Ningi, said that there is wide support for Pate’s appointment: “He is a minister to look out for because of his pedigree. I have no doubt that Prof Pate has come to add value to our nation.” .

Toyin Saraki, founder of the Wellbeing Foundation Africa and Global Health Ambassador for the WHO Foundation, described Pate’s latest position as an exceptional appointment. 

“With a track record of bridging gaps and evidence-driven actions and advocacy for equitable healthcare, Dr Pate is poised to bring about revolutionary changes in Nigeria’s healthcare system,” she said.

She expressed confidence that under Pate’s guidance, Nigeria’s health and social welfare sectors will “once again witness remarkable advancements, improved access to healthcare services, and a renewed focus on the wellbeing of every individual, shaping a brighter healthcare landscape for generations to come”.

Europe’s health systems are facing a perfect storm of challenges, with a post-COVID budget crunch, ageing population and health workforce crisis threatening long-term stability.

BAD HOFGASTEIN, Austria – European health systems, among the best-funded and most equitable in the world, face a barrage of threats to their long-term stability, highlighting the difficulty of achieving and maintaining universal health coverage even in the world’s wealthiest regions.

Experts and political leaders from across the World Health Organization’s (WHO) European region are gathered at the annual European Health Forum meeting in the idyllic resort town of Bad Hofgastein, Austria, this week to debate how to navigate Europe through the labyrinth of threats to the universal health care enjoyed by most of its citizens.

A rapidly ageing population, growing healthcare worker shortages, underinvestment in health systems and external shocks such as climate change and inflation driven by the Russian invasion of Ukraine are putting Europe’s healthcare systems through a battery of stress tests as the bloc looks to move on from the COVID-19 pandemic.

The threats faced by health systems of the European Union are shared across the WHO European region, which includes non-EU Scandinavian countries, Switzerland, the United Kingdom, Turkey, Russia and former Soviet Republics.

“The time is ticking on climate, the time is ticking on demographics, and on sustainability in economic terms,” said Sandra Gallina, Director General for Health and Food Safety at the European Commission. “We are talking about very sophisticated [health] systems … now we need to somehow make them sustainable.”

Post-COVID budget crunch threatens health systems

Christopher Fearne, Malta’s Deputy Prime Minister and Health Minister, was the President of the 73rd World Health Assembly.

The European Union is moving on from the COVID era, but the end of crisis legislation is threatening to create a new set of crises of its own.

During the COVID-19 emergency, EU countries were granted the flexibility to spend beyond the 3.5% annual budget spending deficit mandated by the bloc, allowing countries with strong and weak healthcare systems alike to spend as they saw fit to respond to the virus.

That leniency is set to end on December 31, 2023, and as governments face massive cuts to overall public spending, health is likely to be one of the first items on the chopping block.

“Coupled with inflation and shrinking economies, governments have much less to spend and will have much less leeway with the budgets than they have now,” said Christopher Fearne, deputy prime minister of Malta and Europe’s longest-serving health minister. “The biggest victim of all of this could very well be health.”

Fearne is one of many European Union health ministers who will need to cut back on health spending if the bloc’s rigid budgetary rules are put back in place come January.

“The budgets member states will present to the [EU] Commission in October of this year are already starting to reflect this,” said Fearne. “Government spending will have to come down drastically, and of course, health is going to be one of the spheres which will be impacted.”

But Fearne and his fellow ministers argue there is a clear solution: count health as an investment, not a cost against national budgets.

“We need to look at this question of whether health spending should be reflected in the national budgets – at the moment, it is,” said Fearne. “This means next year governments are going to be very, very, very, very tight with spending.”

Government budget cuts are poised to deliver a shock to the health sector, which is already grappling with the new costs of climate change and the ongoing cost-of-living crisis. Efforts to decarbonize national health systems are also likely to be deprioritized as governments triage increasingly scarce funding.

Health experts warn that the cuts could have a devastating impact on the quality of care for Europeans. Longer wait times, reduced access to services, and a decline in the quality of care are all likely consequences of the cuts.

If public spending on health across the bloc falls, Fearne warned, the door will be left open for private industry to step into the vacuum in Europe’s health sector, with unpredictable results.

The EU health budget passed in 2021 earmarked a record €5.4 billion for spending on health – 11 times the amount apportioned in the previous budget for the 2014-2020 period.

Budgets still consider health a cost, not an investment

Sandra Gallina is the Director General for Health and Food Safety at the European Commission.

In principle, European Commission officials such as Gallina agree with the notion of health as an investment.

“People started to believe a bit more in the words ‘investing in health’: that health is not a cost, but is an investment,” Gallina said, discussing the evolving attitudes of EU officials during the COVID-19 crisis. “Now, not all believe in it, but I believe that [among] a fair share of the actors around me, meaning the people that in the end decide … there was a paradigm shift.”

However, Gallina was more measured in her response to concerns about the pressure on the budget of smaller EU member states raised by Fearne on Wednesday, clarifying that “no promises” could be made that health might be exempted from the budget crunch.

“Budget discipline is budget discipline,” Gallina said. “The only gloomy part I have in my toolbox is that I need to find sustainability soon, meaning economic viability which is good for the budgets of member states.”

Gallina added that Europe needs to find a way to balance the need for financial sustainability with maintaining the high-quality public health system that is, and should remain, a key pillar of the EU’s identity. She held up the heavily privatized healthcare system in the United States, which she had just visited after attending the United Nations General Assembly in New York City last week, as an example of what she does not want for Europe.

“Europe is a good place and we need to protect it,” she said. “We need to not let it erode and arrive at a different reality which is not Europe.”

Dr Hans Kluge, director of the World Health Organization’s European Region, warned that the historic rise in economic inequality amid record profits for private corporations is undermining the resilience of health systems in Europe and around the world.

“We have never seen that extreme poverty and extreme wealth have risen simultaneously and sharply,” said Kluge. “We see giant corporations paying almost no, or few taxes, having unimaginable benefits, while for the first time in recent history, we have more and more children going to bed in the evening with a hungry stomach in the richest countries in our region.”

“Our region is not the disaster-resilient region it used to be,” he said.

Europe’s health workforce crisis: a ‘ticking time bomb’ 

Despite having more doctors, nurses, and primary care workers than ever before, Europe faces a paradox: the shortage of health workers is growing, is larger than it has been in decades, and is still worsening.

Today, the World Health Organization’s 53-member European region is short an estimated 1.8 million health workers. That number is expected to climb to 4 million by 2030 if nothing is done to correct its course.

“The number one problem is the health worker crisis we have here in Europe because there is no health without the health workforce,” said Kluge. “We are facing a ticking time bomb.”

The COVID-19 pandemic exposed and exacerbated the deep-rooted problems facing Europe’s health workforce. Burnout, low pay, and dangerous working conditions are driving healthcare workers away from hospitals across the continent in droves.

Around 40% of healthcare workers are grappling with depression and anxiety, while 70% report feeling burned out, according to the ‘Time to Act’ WHO Europe report published last year.

Attrition rates among health workers are climbing, and as they do, more stress is placed on those who stay.

“Some steps have been taken, but not enough has been done,” said Alvaro Cerame, chairperson for the Medical Workforce Committee of the European Junior Doctors Association. “We need to be a political priority.”

Nearly 50,000 European health workers lost their lives to COVID-19. Those who survived the pandemic continue to struggle through high burdens from mental health, physical exhaustion, and the death of colleagues — from COVID or suicide — which make remaining on the frontlines unbearable for many.

“Let’s remember these are the brave souls who saved society on the frontline of the pandemic,” said Kluge. “The health providers I meet, they love what they do.”

“It is not a job, It’s a vocation,” he said. “The people leaving the workforce simply have no choice, and the despair I see is — truly, as a medical doctor myself — really heartbreaking.”

UK health worker strikes are a warning shot

Strikes across the UK’s National Health Service have resulted in over one million cancelled medical appointments to date.

Subpar pay and hazardous working conditions have sparked healthcare worker strikes across Europe. The ongoing strikes in the United Kingdom, which have snowballed into an uncontrollable crisis that just passed the bleak milestone of one million cancelled medical appointments, are a warning to other European countries of the consequences of neglecting their health workforce.

“There are strikes that then create huge issues, but it is not the moment of the strike that is important — it’s the long-term vision of where you get the staff and how we deal with staff shortages,” said Gallina. “We need to be better at planning and forecasting needs for the workforce.”

Europe’s doctors are also ageing out of work at an alarming rate, and the continent is not churning out enough new doctors to replace them. On average, 30% of doctors in Europe are over 55, and in 13 countries, at least 40% of doctors are over 55 and will retire within the next decade. Italy has the oldest medical workforce in Europe, with nearly 60% of doctors over the age of 55.

If more people in the health workforce today leave, the gap will grow into a gulf, with potentially disastrous consequences for healthcare quality and access.

“We need first to focus on retaining the health workers we already have because it takes a long time to produce more,” said Kluge. “So let’s retain and motivate the people we have by improving their working conditions and making the profession more attractive.”

Europe’s Aging Population: A Challenge for Healthcare

Percentage of medical doctors in WHO European region countries aged 55 and older, 2020 or latest.

Beyond Europe’s ageing doctors lies a more fundamental problem: a rapidly ageing population. As people live longer, they are more likely to develop chronic diseases, which can put a strain on healthcare resources.

The demographic shift has already prompted many European countries, including France, to raise the retirement age in order to correct budgetary imbalances that emerge when too few working people support a system of socialized healthcare and pension benefits.

While Europe’s demographic evolution towards an older society is inevitable, the solution over the long term, experts say, must be to reduce the pressure created by avoidable demands on the healthcare system in the first place. That means ensuring that more people enjoy more “healthy life years” through middle age and as they grow older.

This can be achieved through promoting health literacy and proactively combating avoidable health problems like obesity through education and awareness-raising, as well as tax, environment, and food policies that enable healthier choices and lifestyles.

“Expecting to turn a big tanker of more than 500 million people fast is not fair,” said Gallina. “[But] where we want to arrive is a future that is sustainable for everybody, where is no inequality within countries or within member states.”

Image Credits: EHFG, Chris Marchmant.

Pedestrians in Bangladesh cover their faces to keep from breathing in dust and smog.

Air pollution causes seven million premature deaths every year – yet a minuscule 1% of international development funding ($17.3 billion) and 2% of international public climate finance ($11.6 billion) was allocated to reducing it between 2015 and 2021.

This is according to the Clean Air Fund’s (CAF) report on global air quality funding released on Thursday.

The funders included are multilateral development banks such as the World Bank, bilateral development agencies and governments that fund low- and middle-income countries via loans and grants. 

During the same period, development funders committed almost three times as much money ($47.4 billion) to fossil fuel-prolonging projects, primarily oil and gas extraction and production, according to the report.

More positively, funding for fossil fuel-prolonging projects declined over time and by  2021, outdoor air quality funding ($2.3 billion) exceeded investments in fossil fuel-prolonging projects ($1.5 billion) for the first time. 

Transport

Funding for climate and air pollution leaned heavily towards transport projects, accounting for almost half the outdoor air quality funding ($6.5 billion). These include investments in cleaner fuels, electric and hybrid vehicles, public transport and railways.

Outdoor air quality funding peaked in 2019 mainly due to a large railway project in the Philippines aimed at alleviating serious traffic congestion and mitigating air pollution. It plunged by 65% in 2020, likely because of the COVID-19 pandemic, then rose 37% in 2021.

Co-benefits

“While the pool of funding that is explicitly working to improve outdoor air quality is limited, there is a larger bucket of international development finance which delivers outdoor air quality improvements as a co-benefit of the investment,” according to the report.

This “bucket” is substantial in comparison to the small cup of financing purely for air pollution, amounting to $101 billion or 4% of total international development funding committed in the period.

While CAF welcomed this spending, it added that “an explicit focus on the air quality aspects would make for better-designed projects that deliver stronger returns on the investment.”

Money monopolised

The money doesn’t always go where it is needed most. A staggering 86% of funds for outdoor air quality improvement went to five countries: China (37%), Philippines (20%), Bangladesh (17%), Mongolia (6%) and Pakistan (6%). 

India and Nepal have the highest population-weighted exposure to air pollution  (PM2.5), yet they each received less than 1% of the total. 

Meanwhile, Africa received 5% although five of the top 10 countries with the highest average PM2.5 exposure are on the continent.

The Beijing-Tianjin-Hebei Air Quality Improvement Program received the lion’s share of funding.

At a city level, China’s Beijing (27%), Bangladesh’s Dhaka (9%) and Mongolia’s Ulaanbaatar (6%) received the biggest allocations – despite Delhi, Kokkata and Kano being the worst polluted cities.

Lack of monitoring

The report is concerned about the lack of both modelling and monitoring. At least one billion people live in countries where their governments don’t monitor air quality, Meanwhile, in sub-Saharan Africa research shows one monitor per 28 million people.

“Monitoring local air quality benefits – particularly in relation to health – can help to deliver a more comprehensive understanding of the effects of global climate interventions, allowing for more informed decision-making and resource prioritisation,” the report argues.

Ways to pay

Some 92% of funds to prevent outdoor air pollution were in the form of loans. Multilateral development finance institutions (DFIs) provided slightly over half the funding (51%), followed by bilateral DFIs (37%), then governments (7%).

However, the report recommends making “fuller use of the diverse financial toolbox” to “expand the capital base available for cleaning our air.”

It offers a number of suggestions. For multilateral development banks (MDBs), it suggests initiatives such as partnering with private and public investors to expand investment in clean air projects and provide debt capital to local financial institutions through on-lending structures.

For donor countries, the report proposes substantially increasing the outdoor air quality funding by making more grant and concessional finance available, and “recalibrating investment strategies to ensure key sectors such as agriculture and waste are not left behind.”

Image Credits: Rashed Shumon.

WHO Director-General Dr Tedros Adhanom Ghebreyesus 

Cholera cases doubled last year in comparison to 2021, and preliminary data suggests that 2023 is likely to be even worse, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus told a media briefing on Wednesday.

“So far 28 countries have reported cases this year, compared with 16 during the same period last year,” said Tedros.

Ethiopia, Haiti, Iraq and Sudan have “the most concerning outbreaks”, he added, but noted that “significant progress has been made in countries in southern Africa, including Malawi, Mozambique and Zimbabwe” but these countries remain at risk as the rainy season approaches.

Last week, the WHO released its 2022 cholera report, noting that there had been 472 697 reported cases in 44 countries, in comparison to 223 370 cases in 35 countries in 2021.

“The geographical pattern of outbreaks also changed, as countries that had not reported cholera in many years, including Lebanon and the Syrian Arab Republic, reported large outbreaks in 2022,” according to the report.

It also noted that seven countries reported very large outbreaks of over 10,000 cases – Afghanistan, Cameroon, Democratic Republic of the Congo (DRC), Malawi, Nigeria, Somalia, and Syria.

Tedros said that the “worst affected countries and communities are poor, without access to safe drinking water or toilets” and faced shortages of oral cholera vaccines and overstretched health workers.

 

Almost a year ago, in the face of a huge shortage of oral cholera vaccines, the WHO recommended that people be given a single dose instead of the usual two doses 

The standard preventive approach to cholera is two-dose vaccination with the second dose administered within six months of the first. The immunity of a fully vaccinated person against cholera lasts for three years. While single doses have been used effectively in previous outbreaks,  there is limited evidence on how long protection lasts. The global shortage is projected to last until 2025.

“WHO is providing essential supplies, and coordinating the on-the-ground response with partners, supporting countries to detect, prevent and treat cholera and informing people how to protect themselves,” said Tedros. 

“To support this work, we have appealed for $160 million, and we have released over $16 million from the WHO contingency fund for emergencies. But the real solution to cholera lies in ensuring everyone has access to safe water and sanitation, which is an internationally recognised human right.”

Dr Mike Ryan, WHO’s head of health emergencies, added that cholera outbreaks were sensitive to climatic variability and climatic change, while conflict and resultant displacement of people were driving cases.

Rise in COVID-19 cases

The WHO also expressed concern about the rise in COVID-19 cases, particularly in Europe and the Americas.

“Among the relatively few countries that report them, both hospitalisations and ICU admissions have increased in the past 28 days, particularly in the Americas and Europe,” said Tedros. 

He added that vaccination levels among the most at-risk groups was “worryingly low”, with only a third of people having received a booster shot.

Dr Maria van Kerkhove, WHO’s technical lead on COVID-19, stressed that the vaccines currently available worked on the new variants.

More resources for cervical cancer

Professor Groesbeck Parham

The WHO’s Expert Group on Cervical Cancer Elimination met this week to review progress and advise on the future direction or the initiative.

Addressing the press conference, co-chair Professor Groesbeck Parham, said the group had resolved that there should be a “heavy emphasis on country-specific support for the implementation of the three pillars”, namely HPV vaccination of young girls, cervical cancer screening of adult women, and treatment of women who were found to have pre-cancer or invasive cancer during screening.

“There should be fewer guidelines from WHO but more resources that focus on supporting field workers in the countries that have the highest burden of disease,” said Parham.

The group also felt that all three pillars should be “implemented collectively” and that  “information hubs need to be created that facilitate countries sharing their successes.”

“Rwanda has had great success in vaccinating greater than 90% of their young girls,” he added.

In Ireland, students launched a campaign entitled ‘Not around us’ to promote smoke-free environments in schools.

WHO has stepped up its counteroffensive against tobacco companies that market cigarettes and other tobacco products to teens – with the release of a new set of guidance for school-based anti-smoking policies. 

The guidance, “Freedom from Tobacco and Nicotine: Guide for Schools,” and “Nicotine- and Tobacco-free School Implementation Toolkit”, aims to support school policies banning smoking, vaping and other forms of tobacco use. 

Nearly nine out of 10 smokers begin the habit by the age of 18 – meaning that schools need to be on the frontlines of tobacco control efforts aimed at the next generation. 

“Whether sitting in class, playing games outside or waiting at the school bus stop, we must protect young people from deadly second-hand smoke and toxic e-cigarette emissions as well as ads promoting these products,” said Dr Ruediger Krech, Director of Health Promotion, WHO in a press release describe the new school guidance.

Tobacco epidemic a key concern for youths

The dark shaded areas represent the proportional risk of tobacco use as a factor in key noncommunicable diseases, including heart disease (IHD), stroke, lung disease, cancers (lung, lip, stomach, colorectal) and diabetes.

About 1.8 billion people, or nearly 25% of the world’s population, are between the ages of 18-24.  And more than 80% of these young people live in developing countries, many of which lack strict regulations on tobacco advertising and marketing.  

But the problem of youth-focused marketing of tobacco products extends across nations at all levels of development – as the marketing of vape sticks, e-cigarettes and other tobacco products has shifted to a flourishing online trade. The multi-billion-dollar tobacco industry also has been increasingly active marketing nicotine products, such as e-cigarettes, that resemble youth-appealing characters, school suppliers, toys, and drinks, WHO notes. 

Globally, tobacco is one of the largest risks to health, and for the development noncommunicable diseases; as a result tobacco kills about 8 million people across the globe every year – or more than one person every four seconds. 

“Keeping schools tobacco and nicotine free can help prevent this,” said the WHO in a Twitter post announcing the new guidance, issued just this week.

What’s in the guide? 

Example of a school-based arts and craft project In Krygyzstan promoting anit-tobacco education.

The guide and toolkit offer a step-by-step manual towards creating nicotine- and tobacco-free school campuses by offering advice on policy design; implementation and enforcement; education and awareness-raising campaigns; and smoking cessation programmes. The toolkit and guide highlight four key strategies for schools to adopt and promote: 

  • Banning nicotine and tobacco products on school campuses;
  • Prohibiting the sale and/or distribution of nicotine and tobacco products in school neighborhoods;
  • Banning direct and indirect ads and promotion of nicotine and tobacco products in school neighborhoods; 
  • Refusing offers of sponsorship or engagement with tobacco and nicotine industries. 

The tools and guidance were developed and tested in collaboration with countries that have successfully implemented tobacco and nicotine-free campus policies. Those include: India, Indonesia, Ireland, Morocco, Qatar, Syria, Kyrgyzstan, Saudi Arabia, and Ukraine. 

Samples of nicotine and tobacco-free signage to promote non-smoking school environments.

Release coincides with USD Food and Drug Administration’s warning to online retailers 

Nicotine and tobacco-free campus policies also support healthier lifestyles and waste management, reducing cigarette litter and protecting non-smoking youth from toxic chemicals in second-hand smoke, WHO said. 

The release of the WHO publications coincides with a stiff warning issued recently by the U.S. Food and Drug Administration to 15 online retailers for selling and/or distributing tobacco products that are specifically packaged to appeal to young people. 

“The design of these products is a shamelessly egregious attempt to target kids,” states Brian King, director of FDA’s Center for Tobacco Products, in the notice, issued August 15.

Image Credits: WHO , Institute for Health Metrics and Evaluation (IHME), WHO, WHO/Nicotine and Tobacco Free Schools.

South African President Cyril Ramaphosa visits Aspen Pharmacare manufacturing facility in Gqeberha.

A new deal between Danish company Novo Nordisk and South African generic manufacturer Aspen will massively expand the supply of insulin in sub-Saharan Africa and also transfer the production rights and technology to the African company.

The deal will more than double Novo Nordisk’s production within just one year.  Currently, the pharma company’s insulin products reach 500,000 people living with diabetes in sub-Saharan Africa.  Through the partnership, expanded production will be able to meet the insulin needs of 1.1 million people across the continent by 2024. 

By 2026, the two companies will be able to meet the insulin needs of 4,1 million people living with type 1 and type 2 diabetes across the African continent.

According to the agreement, Novo Nordisk has a minimum purchase obligation from Aspen of €195.5 million for the period 2024-2028.  

“The human insulin will be distributed at low cost to health authorities and non-governmental organisations through government tenders as part of Novo Nordisk’s sustainable business integrated model, iCARE. With iCARE, Novo Nordisk will guarantee a ceiling price of human insulin at $3 per vial,” according to a media release from the company.

“The expanded commitment supports the African Union’s Pharmaceutical Manufacturing Plan for Africa. The collaboration between the partnership allows for local production, storage, and distribution of human insulin in vials in the African continent and means more equitable access to lifesaving care to people with diabetes,” the company added.

Intense engagement with industry based on the Global Diabetes Compact 

The deal was announced jointly by the pharma companies and the World Health Organization (WHO) on the sidelines of a series of high level health-related meetings at the United Nations General Assembly in New York last week. 

The past two years have seen a period of intense WHO engagement with pharma leaders to rev up insulin production following the launch of a WHO Global Diabetes Compact two years ago. 

In 2021, WHO estimated that half of the 63 million people living with Type 2 diabetes could not afford or access insulin, which controls their blood glucose levels. Around 90% of the insulin market is controlled by just three pharma companies: Novo Nordisk, Eli Lilly, and Sanofi.

“Diabetes is on the rise in low- and middle-income countries, but access to insulin has not kept pace with the growing disease burden,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus, addressing an event in New York where the deal with announced. 

“Currently, 24 million adults are living with diabetes in Africa, and that figure is projected to more than double to 55 million by 2045.”

Bente Mikkelson, WHO’s director of the Department of Noncommunicable Diseases, added: “The unmet need for insulin is a stark reminder of the health inequalities that persist in our world today.

“Manufacturers have a pivotal role to play in filling this critical gap, not just with their products but also with their commitment to affordability, accessibility, and sustainable production. This event marks a significant milestone in our collective work to make diabetes treatment and care accessible to those who need it the most, in Africa and around the world,” Mikkelsen said.

“It underscores the power of dialogue and collaboration, where governments, international organisations, and private sector entities come together for a common cause – the cause of humanity.  Together through the Global Diabetes Compact, and with unwavering determination, we’ll script a healthier future for millions in Africa and beyond.”

The Novo Nordisk deal follows on the heels of a partnership announced in May by another leading insulin producer, Eli Lilly with Egypt’s Eva Pharma. As part of the deal, Eva will produce another 1 million “fill and finish” doses of Eli Lilly’s insulin products a year by 2030.

Enabling more local insulin production by Africa

Welcoming the Novo Nordisk partnership with Aspen, South Africa’s Minister of Trade and Industry Ebrahim Patel said that it “will enable the local production of human insulin in South Africa through the conversion of insulin into finished dose vials.”

“This is an excellent first step that we hope will pave the way for both licensing and additional manufacturing opportunities, in areas such as sterile cartridge production and the production of high-demand and the new classes of drugs, such as the glucagon-like peptide-1 (GLP-1), which is largely inaccessible at present to African patients,” Patel said.

The production of insulin will utilise Aspen’s sterile infrastructure in the city of Gqeberha in South Africa, using some of the infrastructure introduced for Aspen’s ill-fated COVID-19 vaccine manufacture.

“We firmly believe that access to quality healthcare is a fundamental human right,” said Katrine DiBona, corporate vice president for Global Public Affairs and Sustainability at Novo Nordisk. 

“We are committed to providing affordable human insulin to ensure access to quality treatments for even more people with diabetes in the African continent. At the same time, it is equally important for us that we are doing it in a sustainable way by focusing on local production.”

World leaders met at a summit last week to discuss how to accelerate progress to achieving the SDG goals by 2030.

At the Sustainable Development Goals Summit last week, world leaders discussed the many ways in which progress toward the Sustainable Development Goals (SDGs) has slowed, stopped, and in some cases retreated. Halfway to the 2030 deadline, half of the 140 targets are off-track and a third are at or below their 2015 baselines. We must reverse this trend.

Achieving the SDGs is even more critical than in 2015, as the world faces unprecedented shocks. The COVID-19 pandemic has taken almost seven million lives and done incalculable damage to health systems. Climate change threatens billions of livelihoods through extreme weather, rising seas, and changing ecosystems. Global conflict is resurgent, and economic inequality and instability are widespread. 

A worrying increase in maternal deaths after decades of improvement is just one example of how easily progress can be reversed, and our public health networks and infrastructure cannot begin to meet the need.

In short, it is a time for reckoning and for action. A time to acknowledge that achieving the SDGs is not the responsibility of governments and philanthropists alone. We need everyone at the table, from grassroots civil society to academia, the private sector and multilateral finance and banking institutions, if we are going to accelerate progress on the SDGs. 

Unprecedented cooperation

But there are lessons to be learnt in every crisis. On that front, at least, the global public health community is ahead of the curve, with the interrelated crises we face eliciting unprecedented levels of cooperation and data-sharing among public and private, global and local actors. 

This period of deterioration in health services and quality of life for so many has also been one of the most productive periods in research in recent memory. That is especially true when it comes to the complexities of multinational programs and the cascading, multiplicative effects of crisis. 

The need for cooperation is the broadest and most common theme to address at this mid-point in our shared work toward the SDGs. What the last seven years have shown us is that government and philanthropy alone lack the tools, resources and insight needed to achieve change on this scale. While both are indispensable, their efforts must be tightly linked to those of global financial institutions, civil society in every nation, and – perhaps most vitally – local organizations that understand how best to reach and support the most vulnerable members of their communities.  

The flip side of that need for cooperation involves industries that are actively hampering progress toward SDGs. For-profit industries that harm health and the environment can’t be part of the solution as long as they are part of the problem. 

Tobacco offers a clear example; with SDG 3 dependent on reducing rates of smoking, tobacco companies have simply shifted focus away from well-regulated markets to target young people and markets in developing regions. Limiting their access, disinvesting from their companies, and cutting them out of global conversations are just as important as paying for preventive care or addressing the shortage of health care workers.

Reimagining our solutions

The UN has identified 12 high-impact initiatives to boost SDG progress, and these will be a key part of discussions around the summit. Bringing these initiatives from discussion to action will require concerted collaboration and innovative partnerships.

Here are four of the initiatives that illustrate the value of partnerships, how progress or setbacks in one goal inevitably affect the others, and the critical role public health plays across the SDGs.

Scaling up long-term, affordable financing for the SDGs

The best plans and goals are pointless if countries don’t have the means to implement them. In July, UNDP published a policy brief arguing that in many low- and middle-income countries, the debt burden is draining resources that should be invested in achieving the SDGs. In 2022, 25 countries spent more than 20% of government revenues on external debt service; the average low-income country spends 2.3 times more on interest than on social assistance. 

The authors propose adding “debt pauses” to the international financial architecture to give developing economies room to grow—and recover from shocks such as COVID-19—while also improving people’s lives.

Bringing international finance institutions to the table is one example of a potential partnership that could boost progress on SDGs, especially the first one: “End poverty in all its forms everywhere.” And ending poverty is key to progress across the SDGs.

Food systems transformation 

World hunger has increased in recent years, with an estimated 9.2% of the world’s population in a state of chronic hunger in 2022. At the same time, the international development community has been slow to look beyond hunger to malnutrition and food insecurity in all of its forms. 

The high-impact initiative on food systems transformation recognizes that we need to change our food systems, so they provide healthy, nutritious food for all, in line with SDG 2, which seeks to end hunger, achieve food security and improved nutrition, and promote sustainable agriculture.

At Vital Strategies, our Food Policy Program has been supporting our civil society partners in sounding the alarm about the health risks of ultra-processed foods high in salt, fat and sugar that international corporations market mercilessly—including to children—despite the proven health risks. 

These cheap, unhealthy products have made it more difficult for people to consume nutritious, traditional diets. The ubiquitous nature of ultra-processed foods exposes billions of people to a higher risk of noncommunicable diseases, including type 2 diabetes, heart disease, stroke and cancer.

Poor nutrition is responsible for 11 million deaths from NCDs annually, killing more people than tobacco. Our Food Policy team has supported civil society partners in Barbados, Brazil, Colombia, Jamaica and South Africa to work toward proven healthy food policies such as taxes on sugary drinks and front-of-package warning labels on ultra-processed products. These policies are just one component of the food systems transformation that has to happen—but a critical one.

Unlocking the data dividend for the SDGs

Regardless of the issue, “data is the fuel that powers progress across all the SDGs,” and investments in data return an average “dividend” of $32 for every $1 invested. Data is especially important in health. We simply cannot address pressing health challenges without the data to guide us. That is why strengthening data collection and shoring up national civil registration and vital statistics systems is an integral part of Vital Strategies’ work. 

Vital Strategies is proud to be a leader in this kind of big-picture, cross-sector collaborative thinking. We partner and work with governments to expand the use of data to identify problems and potential solutions, particularly concerning equity. 

During the COVID-19 pandemic, Vital’s Data for Health team partnered with 13 countries in rapid mortality surveillance—a way to track the true human toll of the pandemic by comparing recent mortality rates to historic averages. These are the kinds of partnerships that drive real progress, but we need the political leadership and investment to make them happen. 

We also need to invest in gender-based statistics so that government stakeholders can rely on applicable data to build policies and programs that will close gender equity gaps. By applying a gender lens to data collection and analysis, we can address a broad range of gender-sensitive policy issues, such as ensuring that all girls are registered at birth, reducing barriers to reproductive health care and treatment, and preventing gender-based violence. 

In Brazil, for example, Vital Strategies’ research uncovered a hidden epidemic of femicide and domestic violence. By selecting mortality data for which the cause of death was unknown, investigators were able to attribute many of these deaths to gender-based violence. We spotlighted other examples of using data to address violence against women at a VitalTalks event in May, “Can Data End Gender-Based Violence?”  

Pulling together

In a special SDG report released in July, UN Secretary-General António Guterres issued a stark warning: “Unless we act now, the 2030 Agenda could become an epitaph for a world that might have been.” 

Affordable financing and debt restructuring—as described in the SDG Stimulus—top his list of critical actions, along with reforming “our outdated, dysfunctional and unfair international financial architecture.” But the U.N., governments and donors can’t go it alone. 

At the halfway point to 2030 and the SDG deadline, we all need to pull together. Without active participation by all stakeholders, the SDGs will fail. I wish the forecast were brighter. But it is clear. Clear that our current actions are falling short, and this is a critical moment if we are to make the world the safe, healthy, prosperous place that I know it can be, for everyone.

José Luis Castro is the President and CEO of Vital Strategies, where he has led a rapid expansion of Vital Strategies’ portfolio to tackle the world’s most difficult health challenges, primarily in low- and middle-income countries. The organization now works in 73 countries and has touched the lives of more than 2 billion people.

Image Credits: Cia Pak/ United Nations, Vital Strategies.